IGLL1
Basic information
Region (hg38): 22:23573125-23580302
Previous symbols: [ "IGLL" ]
Links
Phenotypes
GenCC
Source:
- agammaglobulinemia 2, autosomal recessive (Limited), mode of inheritance: AR
- autosomal agammaglobulinemia (Supportive), mode of inheritance: AD
- agammaglobulinemia 2, autosomal recessive (Limited), mode of inheritance: Unknown
- agammaglobulinemia 2, autosomal recessive (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Agammaglobulinemia 2, autosomal recessive | AR | Allergy/Immunology/Infectious | Antiinfectious prophylaxis (including with administration of IVIG) and early and aggressive treatment of infections may be beneficial | Allergy/Immunology/Infectious | 9419212; 10077633; 10590911 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IGLL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 46 | 56 | ||||
missense | 96 | 12 | 12 | 120 | ||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 11 | 11 | ||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 8 | 3 | 11 | |||
non coding | 12 | |||||
Total | 0 | 0 | 113 | 62 | 28 |
Variants in IGLL1
This is a list of pathogenic ClinVar variants found in the IGLL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-23573153-T-G | Benign (Jun 19, 2021) | |||
22-23573183-G-A | Benign (Jun 19, 2021) | |||
22-23573270-G-A | not specified | Uncertain significance (Jan 31, 2024) | ||
22-23573275-T-C | Agammaglobulinemia 2, autosomal recessive | Likely benign (Mar 17, 2023) | ||
22-23573284-G-A | Agammaglobulinemia 2, autosomal recessive | Benign (Mar 16, 2023) | ||
22-23573289-C-T | Agammaglobulinemia 2, autosomal recessive | Uncertain significance (Nov 01, 2022) | ||
22-23573290-C-T | Agammaglobulinemia 2, autosomal recessive | Likely benign (Dec 20, 2023) | ||
22-23573291-G-A | Agammaglobulinemia 2, autosomal recessive | Uncertain significance (Oct 05, 2023) | ||
22-23573292-T-A | Agammaglobulinemia 2, autosomal recessive | Conflicting classifications of pathogenicity (Dec 20, 2023) | ||
22-23573294-T-A | not specified | Uncertain significance (Aug 16, 2022) | ||
22-23573299-C-T | Agammaglobulinemia 2, autosomal recessive | Likely benign (Dec 18, 2023) | ||
22-23573299-CACG-TGCA | Agammaglobulinemia 2, autosomal recessive | Uncertain significance (Apr 23, 2019) | ||
22-23573300-A-G | Agammaglobulinemia 2, autosomal recessive | Uncertain significance (Dec 18, 2023) | ||
22-23573300-ACG-A | Agammaglobulinemia 2, autosomal recessive | Uncertain significance (Aug 28, 2021) | ||
22-23573301-C-T | Agammaglobulinemia 2, autosomal recessive | Uncertain significance (Nov 25, 2023) | ||
22-23573302-G-A | Agammaglobulinemia 2, autosomal recessive | Likely benign (Dec 18, 2023) | ||
22-23573302-G-C | Agammaglobulinemia 2, autosomal recessive | Likely benign (Aug 20, 2022) | ||
22-23573303-G-C | Agammaglobulinemia 2, autosomal recessive • not specified | Uncertain significance (Nov 10, 2023) | ||
22-23573313-C-T | Agammaglobulinemia 2, autosomal recessive | Uncertain significance (Dec 08, 2022) | ||
22-23573314-G-A | Agammaglobulinemia 2, autosomal recessive | Likely benign (Feb 01, 2024) | ||
22-23573314-G-T | Agammaglobulinemia 2, autosomal recessive | Uncertain significance (Jan 11, 2024) | ||
22-23573318-A-C | Agammaglobulinemia 2, autosomal recessive | Uncertain significance (Jun 24, 2021) | ||
22-23573318-A-G | Agammaglobulinemia 2, autosomal recessive | Uncertain significance (Oct 13, 2023) | ||
22-23573320-G-A | Agammaglobulinemia 2, autosomal recessive | Likely benign (Jan 11, 2024) | ||
22-23573323-C-A | Agammaglobulinemia 2, autosomal recessive | Uncertain significance (Nov 21, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IGLL1 | protein_coding | protein_coding | ENST00000330377 | 3 | 7184 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0139 | 0.690 | 125492 | 1 | 247 | 125740 | 0.000987 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.298 | 134 | 125 | 1.07 | 0.00000793 | 1326 |
Missense in Polyphen | 23 | 21.311 | 1.0793 | 281 | ||
Synonymous | -1.52 | 73 | 58.2 | 1.25 | 0.00000419 | 452 |
Loss of Function | 0.596 | 3 | 4.34 | 0.691 | 1.87e-7 | 42 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000593 | 0.000593 |
Ashkenazi Jewish | 0.00179 | 0.00179 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00178 | 0.00178 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000294 | 0.000261 |
Other | 0.000651 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Critical for B-cell development. {ECO:0000269|PubMed:9419212}.;
- Pathway
- Primary immunodeficiency - Homo sapiens (human);Cell surface interactions at the vascular wall;Hemostasis
(Consensus)
Recessive Scores
- pRec
- 0.285
Haploinsufficiency Scores
- pHI
- 0.0666
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0989
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Igll1
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- phagocytosis, recognition;phagocytosis, engulfment;immune response;complement activation, classical pathway;defense response to bacterium;innate immune response;B cell receptor signaling pathway;positive regulation of B cell activation;leukocyte migration
- Cellular component
- extracellular region;external side of plasma membrane;membrane;immunoglobulin complex, circulating
- Molecular function
- antigen binding;immunoglobulin receptor binding